Terms: = Pancreatic cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Prognosis
18 results:
1. Resistance to Gemcitabine in pancreatic cancer Is Connected to Methylglyoxal Stress and Heat Shock Response.
Crake R; Gasmi I; Dehaye J; Lardinois F; Peiffer R; Maloujahmoum N; Agirman F; Koopmansch B; D'Haene N; Azurmendi Senar O; Arsenijevic T; Lambert F; Peulen O; Van Laethem JL; Bellahcène A
Cells; 2023 May; 12(10):. PubMed ID: 37408249
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a New m6A Regulator-Related Methylation Signature for Predicting the prognosis and Immune Microenvironment of Patients with pancreatic cancer.
Zou T; Shi D; Wang W; Chen G; Zhang X; Tian Y; Gong P
Mediators Inflamm; 2023; 2023():5565054. PubMed ID: 37181810
[TBL] [Abstract] [Full Text] [Related]
3. Stress-Inducible SCAND Factors Suppress the Stress Response and Are Biomarkers for Enhanced prognosis in cancers.
Sheta M; Yoshida K; Kanemoto H; Calderwood SK; Eguchi T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982267
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of plasma LC3B
Chen YQ; Zheng L; Zhou J; Wang P; Wang L; Zhang Y; Man ZS; Chen YH; Gu F; Niu GP
Int Immunopharmacol; 2022 Jul; 108():108760. PubMed ID: 35398623
[TBL] [Abstract] [Full Text] [Related]
5. Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis.
Ji F; Zhou M; Sun Z; Jiang Z; Zhu H; Xie Z; Ouyang X; Zhang L; Li L
Cancer Commun (Lond); 2021 Oct; 41(10):1007-1023. PubMed ID: 34196494
[TBL] [Abstract] [Full Text] [Related]
6. Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma.
Grbovic-Huezo O; Pitter KL; Lecomte N; Saglimbeni J; Askan G; Holm M; Melchor JP; Chandwani R; Joshi S; Haglund C; Iacobuzio-Donahue CA; Chiosis G; Tammela T; Leach SD
Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30670-30678. PubMed ID: 33199632
[TBL] [Abstract] [Full Text] [Related]
7. Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes pancreatic Tumors to Proteotoxic Stress.
Tomihara H; Carbone F; Perelli L; Huang JK; Soeung M; Rose JL; Robinson FS; Lissanu Deribe Y; Feng N; Takeda M; Inoue A; Poggetto ED; Deem AK; Maitra A; Msaouel P; Tannir NM; Draetta GF; Viale A; Heffernan TP; Bristow CA; Carugo A; Genovese G
Cancer Res; 2021 Jan; 81(2):332-343. PubMed ID: 33158812
[TBL] [Abstract] [Full Text] [Related]
8. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
[TBL] [Abstract] [Full Text] [Related]
9. Stress-induced phosphoprotein 1 promotes pancreatic cancer progression through activation of the FAK/AKT/MMP signaling axis.
Jing Y; Liang W; Liu J; Zhang L; Wei J; Zhu Y; Yang J; Ji K; Zhang Y; Huang Z
Pathol Res Pract; 2019 Nov; 215(11):152564. PubMed ID: 31547977
[TBL] [Abstract] [Full Text] [Related]
10. Bovine Hemoglobin Derived Peptide Asn-Phe-Gly-Lys Inhibits pancreatic cancer Cells Metastasis by Targeting Secreted hsp90α.
Wang Y; Zhang T; Zhang H; Yang H; Li Y; Jiang Y
J Food Sci; 2017 Dec; 82(12):3005-3012. PubMed ID: 29083493
[TBL] [Abstract] [Full Text] [Related]
11. Heat Shock Protein 90 Is a Potential Therapeutic Target in Cholangiocarcinoma.
Shirota T; Ojima H; Hiraoka N; Shimada K; Rokutan H; Arai Y; Kanai Y; Miyagawa S; Shibata T
Mol Cancer Ther; 2015 Sep; 14(9):1985-93. PubMed ID: 26141945
[TBL] [Abstract] [Full Text] [Related]
12. Gene expression analysis for evaluation of potential biomarkers in hepatocellular carcinoma.
Hass HG; Jobst J; Scheurlen M; Vogel U; Nehls O
Anticancer Res; 2015 Apr; 35(4):2021-8. PubMed ID: 25862856
[TBL] [Abstract] [Full Text] [Related]
13. Use of herbal medicines and natural products: an alternative approach to overcoming the apoptotic resistance of pancreatic cancer.
Li L; Leung PS
Int J Biochem Cell Biol; 2014 Aug; 53():224-36. PubMed ID: 24875648
[TBL] [Abstract] [Full Text] [Related]
14. Heat-shock protein 90 inhibitors synergistically enhance melanoma differentiation-associated gene-7-mediated cell killing of human pancreatic carcinoma.
Zhang Z; Kawamura K; Jiang Y; Shingyoji M; Ma G; Li Q; Hu J; Qi Y; Liu H; Zhang F; Kang S; Shan B; Wang S; Chada S; Tagawa M
Cancer Gene Ther; 2013 Dec; 20(12):663-70. PubMed ID: 24263157
[TBL] [Abstract] [Full Text] [Related]
15. Melatonin influences pancreatic cancerogenesis.
Jaworek J; Leja-Szpak A
Histol Histopathol; 2014 Apr; 29(4):423-31. PubMed ID: 24258787
[TBL] [Abstract] [Full Text] [Related]
16. Potent antitumor activity of the novel hsp90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells.
Zitzmann K; Ailer G; Vlotides G; Spoettl G; Maurer J; Göke B; Beuschlein F; Auernhammer CJ
Int J Oncol; 2013 Dec; 43(6):1824-32. PubMed ID: 24100469
[TBL] [Abstract] [Full Text] [Related]
17. Oxidative inhibition of hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo.
Sarkar S; Dutta D; Samanta SK; Bhattacharya K; Pal BC; Li J; Datta K; Mandal C; Mandal C
Int J Cancer; 2013 Feb; 132(3):695-706. PubMed ID: 22729780
[TBL] [Abstract] [Full Text] [Related]
18. Concomitant inhibition of hsp90, its mitochondrial localized homologue TRAP1 and HSP27 by green tea in pancreatic cancer HPAF-II cells.
Zhang L; Pang E; Loo RR; Rao J; Go VL; Loo JA; Lu QY
Proteomics; 2011 Dec; 11(24):4638-47. PubMed ID: 22116673
[TBL] [Abstract] [Full Text] [Related]
